BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8638620)

  • 1. Translocation 21;22 may be involved in control of differentiation in erythroleukemia.
    Fujisawa S; Motomura S; Fujimaki K; Okubo T
    Am J Hematol; 1996 May; 52(1):65. PubMed ID: 8638620
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential expression of TCL1 during pre-B-cell acute lymphoblastic leukemia progression.
    Fears S; Chakrabarti SR; Nucifora G; Rowley JD
    Cancer Genet Cytogenet; 2002 Jun; 135(2):110-9. PubMed ID: 12127395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Fagnan A; Bagger FO; Piqué-Borràs MR; Ignacimouttou C; Caulier A; Lopez CK; Robert E; Uzan B; Gelsi-Boyer V; Aid Z; Thirant C; Moll U; Tauchmann S; Kurtovic-Kozaric A; Maciejewski J; Dierks C; Spinelli O; Salmoiraghi S; Pabst T; Shimoda K; Deleuze V; Lapillonne H; Sweeney C; De Mas V; Leite B; Kadri Z; Malinge S; de Botton S; Micol JB; Kile B; Carmichael CL; Iacobucci I; Mullighan CG; Carroll M; Valent P; Bernard OA; Delabesse E; Vyas P; Birnbaum D; Anguita E; Garçon L; Soler E; Schwaller J; Mercher T
    Blood; 2020 Aug; 136(6):698-714. PubMed ID: 32350520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.
    Ohki M
    Semin Cancer Biol; 1993 Dec; 4(6):369-75. PubMed ID: 8142622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
    de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
    Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AML1 and Pebp2: the gene for a transcription factor is involved in recurring translocations in human acute myeloid leukemia.
    Rowley JD
    Jpn J Cancer Res; 1994 Dec; 85(12):inside front cover. PubMed ID: 7852178
    [No Abstract]   [Full Text] [Related]  

  • 9. The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation.
    Aerbajinai W; Giattina M; Lee YT; Raffeld M; Miller JL
    Blood; 2003 Jul; 102(2):712-7. PubMed ID: 12663450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.
    Vecchiarelli-Federico LM; Liu T; Yao Y; Gao Y; Li Y; Li YJ; Ben-David Y
    Int J Oncol; 2017 Aug; 51(2):456-466. PubMed ID: 28586009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analyses of the mutations of AML 1 gene in myelodysplastic syndromes].
    Yoichi I
    Rinsho Ketsueki; 2002 Mar; 43(3):139-45. PubMed ID: 11979742
    [No Abstract]   [Full Text] [Related]  

  • 12. Low frequency of TEL/AML1 in adult acute lymphoblastic leukemia.
    Kwong YL; Wong KF
    Cancer Genet Cytogenet; 1997 Oct; 98(2):137-8. PubMed ID: 9332479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML1 amplification in a child with acute lymphoblastic leukemia.
    Alvarez Y; Coll MD; Bastida P; Ortega JJ; Caballín MR
    Cancer Genet Cytogenet; 2003 Jan; 140(1):58-61. PubMed ID: 12550760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of leukemogenesis induced by AML 1-MTG 8].
    Kitabayashi I; Ohki M
    Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):26-32. PubMed ID: 10643332
    [No Abstract]   [Full Text] [Related]  

  • 15. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 16. ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation.
    Shirihai OS; Gregory T; Yu C; Orkin SH; Weiss MJ
    EMBO J; 2000 Jun; 19(11):2492-502. PubMed ID: 10835348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML1 gene in human leukemias: dominant negative effects of the chimeric proteins over wild-type AML1.
    Zhang DE
    Jpn J Cancer Res; 1997 Jun; 88(6):inside front cover. PubMed ID: 9263526
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia.
    Cuneo A; Agostini P; Vitale A; Foà R; Castoldi G
    Leukemia; 2003 Feb; 17(2):476-7; author reply 477. PubMed ID: 12592356
    [No Abstract]   [Full Text] [Related]  

  • 19. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.